You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 24 No. 1, January 1971 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Resting Plasma Catecholamine Concentrations in Patients With Depression and Anxiety

Richard J. Wyatt, MD; Barry Portnoy, MD; David J. Kupfer, MD; Frederick Snyder, MD; Karl Engelman, MD

Arch Gen Psychiatry. 1971;24(1):65-70.


Abstract

The total resting plasma catecholamine concentration from 13 drugfree, depressed patients was found to be significantly elevated over concentrations from 47 normal controls. Differential determinations of epinephrine and norepinephrine revealed that both catecholamine components were elevated in the Patients. The literature on norepinephrine concentrations in brain, spinal fluid, and urinary excretion was reviewed and indicated that rather than being decreased, norepinephrine has been found to be either unchanged or increased in depressed patients.



Author Affiliations

Bethesda, Mdn

From the Laboratory of Clinical Psychobiology, National Institute of Mental Health and Branch on Experimental Therapeutics, National Institutes of Health, Bethesda, Md. Dr. Wyatt is now with the Laboratory of Clinical Psychopharmacology, Special Mental Health Research Division, National Institute of Mental Health, St. Elizabeth's Hospital, Washington DC, and Drs. Portnoy and Kupfer are now with Yale New Haven (Conn) Hospial.


Footnotes

Accepted for publication March 10, 1970.

Reprint requests to Laboratory of Clinical Psychobiology, National Institute of Mental Health, Bldg 10, Room 3N222, Bethesda, Md 20014 (Dr. Wyatt).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Depression and heart rate variability in patients with coronary heart disease
CARNEY and FREEDLAND
Cleveland Clinic Journal of Medicine 2009;76:S13-S17.
ABSTRACT | FULL TEXT  

Nighttime Heart Rate and Survival in Depressed Patients Post Acute Myocardial Infarction
Carney et al.
Psychosom. Med. 2008;70:757-763.
ABSTRACT | FULL TEXT  

Depressive Symptoms, Race, and Glucose Concentrations: The role of cortisol as mediator
Boyle et al.
Diabetes Care 2007;30:2484-2488.
ABSTRACT | FULL TEXT  

Association of anger proneness, depression and low social support with peripheral arterial disease: the Atherosclerosis Risk in Communities Study
Wattanakit et al.
Vasc Med 2005;10:199-206.
ABSTRACT  

Depressive Symptoms Predict Norepinephrine Response to a Psychological Stressor Task in Alzheimer's Caregivers
Mausbach et al.
Psychosom. Med. 2005;67:638-642.
ABSTRACT | FULL TEXT  

Depression, the Autonomic Nervous System, and Coronary Heart Disease
Carney et al.
Psychosom. Med. 2005;67:S29-S33.
ABSTRACT | FULL TEXT  

Heart and mind: (1) relationship between cardiovascular and psychiatric conditions
Shah et al.
Postgrad. Med. J. 2004;80:683-689.
ABSTRACT | FULL TEXT  

Effects of Depression on QT Interval Variability After Myocardial Infarction
Carney et al.
Psychosom. Med. 2003;65:177-180.
ABSTRACT | FULL TEXT  

Depressive symptoms and risk of functional decline and death in patients with heart failure
Vaccarino et al.
J Am Coll Cardiol 2001;38:199-205.
ABSTRACT | FULL TEXT  

Psychiatric Side Effects of Interferon Therapy: Prevalence, Proposed Mechanisms, and Future Directions
Trask et al.
JCO 2000;18:2316-2326.
ABSTRACT | FULL TEXT  

Can Treating Depression Reduce Mortality After an Acute Myocardial Infarction?
Carney et al.
Psychosom. Med. 1999;61:666-675.
ABSTRACT | FULL TEXT  

The Relationship of Depression to Cardiovascular Disease: Epidemiology, Biology, and Treatment
Musselman et al.
Arch Gen Psychiatry 1998;55:580-592.
ABSTRACT | FULL TEXT  

Adrenal Gland Volume in Major Depression: Increase During the Depressive Episode and Decrease With Successful Treatment
Rubin et al.
Arch Gen Psychiatry 1995;52:213-218.
ABSTRACT  

Sympathetic Nervous System Activity in Major Depression: Basal and Desipramine-Induced Alterations in Plasma Norepinephrine Kinetics
Veith et al.
Arch Gen Psychiatry 1994;51:411-422.
ABSTRACT  

The Concepts of Stress and Stress System Disorders: Overview of Physical and Behavioral Homeostasis
Chrousos and Gold
JAMA 1992;267:1244-1252.
ABSTRACT  

Blunted Growth Hormone Response to Clonidine in Patients With Generalized Anxiety Disorder
Abelson et al.
Arch Gen Psychiatry 1991;48:157-162.
ABSTRACT  

Cerebrospinal Fluid and Urinary Biogenic Amines in Depressed Patients and Healthy Controls
Davis et al.
Arch Gen Psychiatry 1988;45:705-717.
ABSTRACT  

Afternoon Continuous Plasma Levels of 3-Methoxy-4-hydroxyphenylglycol and Age: Distinctive Biologic Subgroups of Endogenous Depression?
Halbreich et al.
Arch Gen Psychiatry 1987;44:804-812.
ABSTRACT  

Catecholamine Metabolism and Disposition in Healthy and Depressed Subjects
Maas et al.
Arch Gen Psychiatry 1987;44:337-344.
ABSTRACT  

Cerebrospinal Fluid Amine Metabolites: Relations`phips With Behavioral Measurements in Depressed, Manic, and Healthy Control Subjects
Redmond et al.
Arch Gen Psychiatry 1986;43:938-947.
ABSTRACT  

Plasma Norepinephrine Level in Affective Disorders: Relationship to Melancholia
Roy et al.
Arch Gen Psychiatry 1985;42:1181-1185.
ABSTRACT  

Exaggerated Orthostatic Responsivity of Plasma Norepinephrine in Depression
Rudorfer et al.
Arch Gen Psychiatry 1985;42:1186-1192.
ABSTRACT  

Noradrenergic Function and the Mechanism of Action of Antianxiety Treatment: I. The Effect of Long-term Alprazolam Treatment
Charney and Heninger
Arch Gen Psychiatry 1985;42:458-467.
ABSTRACT  

Noradrenergic Function in Panic Anxiety: Effects of Yohimbine in Healthy Subjects and Patients With Agoraphobia and Panic Disorder
Charney et al.
Arch Gen Psychiatry 1984;41:751-763.
ABSTRACT  

Adrenergic Function in Patients With Panic Anxiety
Nesse et al.
Arch Gen Psychiatry 1984;41:771-776.
ABSTRACT  

Body Composition in Affective Disorder Before, During, and After Lithium Carbonate Therapy
Colt et al.
Arch Gen Psychiatry 1982;39:577-581.
ABSTRACT  

The Peripheral Kinetics of Norepinephrine in Depressive Illness
Esler et al.
Arch Gen Psychiatry 1982;39:295-300.
ABSTRACT  

Influence of Small Increments of Epinephrine on Glucose Tolerance in Normal Humans
HAMBURG et al.
ANN INTERN MED 1980;93:566-568.
ABSTRACT  

Plasma Levels of Norepinephrine
KOPIN et al.
ANN INTERN MED 1978;88:671-680.
ABSTRACT  

Behavioral and Psychological Processes in Ischemic Heart Disease
Klein
Arch Intern Med 1977;137:1672-1673.
ABSTRACT  

Evaluation of transcendental meditation as a method of reducing stress
Michaels et al.
Science 1976;192:1242-1244.
ABSTRACT  

Differential Catechol-O-Methyltransferase Activity in Unipolar and Bipolar Affective Illness
Dunner et al.
Arch Gen Psychiatry 1971;25:348-353.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1971 American Medical Association. All Rights Reserved.